Active Ingredient (In Each Lozenge)
Nicotine polacrilex 2 mg
The following Structured Product Label (SPL) was submitted to the FDA by Atlantic Biologicals Corp. for the product Nicotine Mini (NDC 17856-1239). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each lozenge), purpose, use, if you are pregnant or breast-feeding,, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, stop use and ask a doctor if, keep out of reach of children and pets., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Nicotine polacrilex 2 mg
Stop smoking aid
only use this medicine on the advice of your health care provider. Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.
Nicotine lozenges may have enough nicotine to make children and pets sick. If you need to remove the lozenge, wrap it in paper and throw away in the trash. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
| Weeks 1 to 6 | Weeks 7 to 9 | Weeks 10 to 12 |
| 1 lozenge every 1 to 2 hours | 1 lozenge every 2 to 4 hours | 1 lozenge every 4 to 8 hours |
aspartame, calcium polycarbophil, flavor, maltodextrin, mannitol, sodium alginate, sodium bicarbonate, sodium stearyl fumarate, talc, xanthan gum
Call 1-800-645-2158
DISTRIBUTED BY:
ATLANTIC BIOLOGICAL CORPS.
MIAMI, FL 33179
* Please review the disclaimer below.